| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
BARD1 Life Sciences Limited (AU: BD1)
BD1 Technical Analysis
2.5
| As on 9th Feb 2022 BD1 STOCK Price closed @ 1.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.76 & Strong Buy for SHORT-TERM with Stoploss of 0.74 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BD1STOCK Price
| Open | 1.03 | Change | Price | % |
| High | 1.05 | 1 Day | 0.00 | 0.00 |
| Low | 1.03 | 1 Week | 0.02 | 1.96 |
| Close | 1.04 | 1 Month | -0.08 | -7.14 |
| Volume | 38859 | 1 Year | 0.26 | 33.33 |
| 52 Week High 4.10 | 52 Week Low 0.57 | ||||
AU Australia Most Active Stocks
| SYA | 0.03 | % |
| M2R | 0.01 | % |
| ACW | 0.04 | % |
| QPM | 0.04 | % |
| BCB | 0.01 | % |
| YAL | 5.35 | % |
| RED | 0.36 | % |
| LRS | 0.22 | % |
| NAG | 0.02 | % |
| STX | 0.20 | % |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| BD1 Daily Charts |
BD1 Intraday Charts |
Whats New @ Bazaartrend |
BD1 Free Analysis |
|
|
BD1 Important Levels Intraday
| RESISTANCE | 1.08 |
| RESISTANCE | 1.07 |
| RESISTANCE | 1.06 |
| RESISTANCE | 1.05 |
| SUPPORT | 1.03 |
| SUPPORT | 1.02 |
| SUPPORT | 1.01 |
| SUPPORT | 1.00 |
BD1 Forecast September 2024
| 4th UP Forecast | 1.44 |
| 3rd UP Forecast | 1.31 |
| 2nd UP Forecast | 1.23 |
| 1st UP Forecast | 1.15 |
| 1st DOWN Forecast | 0.93 |
| 2nd DOWN Forecast | 0.85 |
| 3rd DOWN Forecast | 0.77 |
| 4th DOWN Forecast | 0.64 |
BD1 Weekly Forecast
| 4th UP Forecast | 1.14 |
| 3rd UP Forecast | 1.11 |
| 2nd UP Forecast | 1.09 |
| 1st UP Forecast | 1.07 |
| 1st DOWN Forecast | 1.01 |
| 2nd DOWN Forecast | 0.99 |
| 3rd DOWN Forecast | 0.97 |
| 4th DOWN Forecast | 0.94 |
BD1 Forecast2024
| 4th UP Forecast | 10.73 |
| 3rd UP Forecast | 7.62 |
| 2nd UP Forecast | 5.7 |
| 1st UP Forecast | 3.78 |
| 1st DOWN Forecast | -1.7 |
| 2nd DOWN Forecast | -3.62 |
| 3rd DOWN Forecast | -5.54 |
| 4th DOWN Forecast | -8.65 |
BARD1 Life Sciences Limited ( AU Australia Symbol : BD1 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BD1 Business Profile
BARD1 Life Sciences Limited engages in the research, development, and commercialization of diagnostic products for the early detection of cancer to enhance patient outcomes in Australia. The company offers hTERT test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for ovarian and breast cancers, and research-stage projects for prostate and other cancers. BARD1 Life Sciences Limited was incorporated in 1983 and is headquartered in Notting Hill, Australia. Address: 23 Normanby Road, Notting Hill, VIC, Australia, 3168
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service